Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.78 |
| ▸ | DGKA | P23743 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | SELP | P16109 | 1/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | PGR | P06401 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.58 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Monolinolenin SCHEMBL23611225 | 1.00 | FAAH (0.78) | FAAHDGKAALDH1A1CYP3A4ALOX15 | |
| SCHEMBL13623309 | 1.00 | FAAH (0.78) | FAAHDGKAALDH1A1CYP3A4ALOX15 | |
| 1-Monolinolenin SCHEMBL18340460 | 1.00 | FAAH (0.78) | FAAHDGKAALDH1A1CYP3A4ALOX15 | |
| 1-Monolinolenin SCHEMBL23611226 | 1.00 | FAAH (0.78) | FAAHDGKAALDH1A1CYP3A4ALOX15 | |
| 1-Monolinolenin SCHEMBL1580284 | 1.00 | FAAH (0.78) | FAAHDGKAALDH1A1CYP3A4ALOX15 | |
| SCHEMBL29376090 | 0.99 | FAAH (0.80) | FAAHDGKAALDH1A1CYP3A4ALOX15 | |
| 1-Monolinolenin SCHEMBL28213368 | 0.97 | FAAH (0.74) | FAAHDGKAALDH1A1CYP3A4ALOX15 | |
| SCHEMBL9905949 | 0.94 | FAAH (0.82) | FAAHDGKAALDH1A1CYP3A4ALOX15 | |
| SCHEMBL15451530 | 0.94 | FAAH (0.82) | FAAHDGKAALDH1A1CYP3A4ALOX15 | |
| SCHEMBL3195987 | 0.93 | ALDH1A1 (0.73) | FAAHDGKAALDH1A1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355564-A1 | CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID MONOGLYCERIDES, METHODS AND USES THEREOF | SCF PHARMA INC. (CA) | 2023-11-09 | — | — | US | disclosed |
| US-20230355564-A1 | CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID MONOGLYCERIDES, METHODS AND USES THEREOF | SCF PHARMA INC. (CA) | 2023-11-09 | — | — | US | disclosed |
| US-11701337-B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | SCF PHARMA INC. (CA) | 2023-07-18 | — | — | US | disclosed |
| US-11701337-B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | SCF PHARMA INC. (CA) | 2023-07-18 | — | — | US | disclosed |
| US-20220133676-A1 | CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID MONOGLYCERIDES, METHODS AND USES THEREOF | SCF PHARMA INC. (CA) | 2022-05-05 | — | — | US | disclosed |
| US-20200316007-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, COMPOSITIONS, METHODS AND USES THEREOF | SCF PHARMA INC. (CA) | 2020-10-08 | — | — | US | disclosed |
| US-10716776-B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | SCF PHARMA INC. (CA) | 2020-07-21 | — | — | US | disclosed |
| US-9925165-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | SCF PHARMA INC. (CA) | 2018-03-27 | — | — | US | disclosed |
| US-9925165-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | SCF PHARMA INC. (CA) | 2018-03-27 | — | — | US | disclosed |
| US-20170014369-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2017-01-19 | — | — | US | disclosed |
| US-20100196496-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2010-08-05 | — | — | US | disclosed |
| US-20100196496-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2010-08-05 | — | — | US | disclosed |
| US-20100160261-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | SCF PHARMA INC. (CA) | 2010-06-24 | — | — | US | disclosed |
| US-20100160261-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | SCF PHARMA INC. (CA) | 2010-06-24 | — | — | US | disclosed |
| US-20090291102-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| US-20090292019-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | SCF PHARMA INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| US-20090291102-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| US-20090292019-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | SCF PHARMA INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| WO-2008113177-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2008-09-25 | — | — | WO | disclosed |
| WO-2008098375-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220133676-A1 | CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID MONOGLYCERIDES, METHODS AND USES THEREOF | CNR2, MGLL, FAAH | FAAH 3/4885DGKA 31/4885ALDH1A1 2613/4885 |
| US-20230355564-A1 | CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID MONOGLYCERIDES, METHODS AND USES THEREOF | CNR2, SGMS2, SGMS1 | FAAH 4/4885DGKA 33/4885ALDH1A1 2976/4885 |
| US-20100196496-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | FAAH 871/4885DGKA 40/4885ALDH1A1 1033/4885 |
| US-20090292019-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | FASN, MGLL, FADS1 | FAAH 225/4885DGKA 36/4885ALDH1A1 695/4885 |
| US-20170014369-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | PPARG, PTGES, PTGIS | FAAH 267/4885DGKA 102/4885ALDH1A1 1476/4885 |
| US-20200316007-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, COMPOSITIONS, METHODS AND USES THEREOF | AGK, GSR, CPT2 | FAAH 106/4885DGKA 45/4885ALDH1A1 3135/4885 |
| US-11701337-B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | CPT2, AGK, GSR | FAAH 120/4885DGKA 130/4885ALDH1A1 2876/4885 |
| US-10716776-B2 | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof | CPT2, GSR, ACADVL | FAAH 528/4885DGKA 235/4885ALDH1A1 2015/4885 |
| US-20090291102-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | MGLL, PNLIP, FASN | FAAH 871/4885DGKA 40/4885ALDH1A1 1033/4885 |
| US-20100160261-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | FASN, MGLL, FADS1 | FAAH 225/4885DGKA 36/4885ALDH1A1 695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.